10x Genomics, Inc. Restricted Cash, Noncurrent
10x Genomics, Inc. (TXG) had Restricted Cash, Noncurrent of $201.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2025-11-07
- 2025-09-30: Restricted Cash, Noncurrent $201.00K.
- 2024-12-31: Restricted Cash, Noncurrent $0.00.
- 2023-12-31: Restricted Cash, Noncurrent $0.00.
- 2023-09-30: Restricted Cash, Noncurrent $2.97M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-07 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-07 |
| 2023-12-31 | $0.00 10-K · filed 2024-02-15 |
| 2023-09-30 | $2.97M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $3.47M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $4.97M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.97M 10-K · filed 2024-02-15 |
| 2022-09-30 | $7.09M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.09M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.60M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.60M 10-K · filed 2023-02-16 |
| 2021-09-30 | $8.60M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $8.60M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $8.60M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $8.47M 10-K · filed 2022-02-18 |
| 2020-09-30 | $5.47M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.00M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $59.48M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $52.33M 10-K · filed 2021-02-26 |
| 2019-09-30 | $50.05M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $5.01M 10-K · filed 2020-02-27 |